Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DWP450 vs Botox for Moderate to Severe Glabellar Lines
CTR20200687Phase 3Completed
- Sponsor
- Daewoong Pharmaceutical
- Start
- Apr 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of botulinum toxin type A in glabellar furrowing, sponsored by Daewoong Pharmaceutical. Started Apr 2020; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
glabellar furrowing
Beyond the preview
Go deeper on CTR20200687.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20200687.